We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 49

Pfizer’s LYRICA patent sufficient, valid and infringed in Australia (but not in the UK)
  • Davies Collison Cave
  • Australia, United Kingdom
  • November 28 2016

In the recent decision of Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) 2016 FCA 1238, the Federal Court has upheld the validity of Pfizer's


Commonwealth entitled to claim on the undertaking as to damages
  • Davies Collison Cave
  • Australia
  • March 17 2016

Last year the Full Federal Court of Australia comprising Justices Dowsett, Kenny and Nicholas was asked to consider the following question: Is the


Costs of patent amendment application not immutable; opponent ordered to pay substantial legal costs
  • Davies Collison Cave
  • Australia
  • May 4 2015

Departing from the near 'immutable rule' that the amending party pay any other party's legal costs of the amendment


Damages recovery by the Commonwealth pursuant to the “usual undertakings”
  • Davies Collison Cave
  • Australia
  • April 29 2015

A recent procedural decision by Nicholas J in the Federal Court provides an interesting snapshot of the issues involved in the recovery of damages by


LG’s comparative advertisement with Samsung for 3D TV was misleading
  • Davies Collison Cave
  • Australia
  • April 28 2015

Samsung issued proceedings against LG for misleading or deceptive conduct and the tort of injurious falsehood in relation to six television


Intellectual Property Laws Amendment Act 2015 update on recent changes to Australia’s intellectual property legislation
  • Davies Collison Cave
  • Australia, New Zealand
  • April 15 2015

The Intellectual Property Laws Amendment Act 2015 (Cth) received Royal Assent on 25 February 2015. Although some changes under the Act came into


Isolated gene sequences are patentable in Australia
  • Davies Collison Cave
  • Australia, USA
  • September 8 2014

In a decision handed down on Friday 5 September 2014 a Full Federal Court consisting of 5 Justices affirmed the decision of Nicholas J at first


Maximising a patentee's legal costs recovery in successful patent litigation
  • Davies Collison Cave
  • Australia
  • June 13 2014

Section 19 of the Patents Act 1990 (Cth) arises infrequently in practice, but its provisions can be of real value to a patentee, as was shown in


Pharmaceutical generic patent indirect infringement victory overturned
  • Davies Collison Cave
  • Australia
  • May 21 2014

In a unanimous decision handed down on 19 May 2014 in Warner-Lambert Co LLC v Apotex Pty Ltd 2014 FCAFC 59 (Warner-Lambert), the Full Court made it


TGA's guidance on clinical trial data and commercially confidential information
  • Davies Collison Cave
  • Australia
  • May 20 2014

The Therapeutic Goods Administration (TGA) recently undertook a review of its treatment of commercially confidential information (CCI), and published